Breedlove Robert Charles 4
4 · Phathom Pharmaceuticals, Inc. · Filed Sep 9, 2025
Insider Transaction Report
Form 4
Breedlove Robert Charles
Principal Accounting Officer
Transactions
- Sale
Common Stock
2025-09-05$12.09/sh−461$5,573→ 47,931 total
Holdings
- 6,945.4(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.